Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
7.60
+0.08 (1.06%)
At close: Jul 10, 2025, 4:00 PM
7.65
+0.05 (0.66%)
Pre-market: Jul 11, 2025, 7:10 AM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $175.05 million as of July 11, 2025. Its market cap has decreased by -12.77% in one year.
Market Cap
175.05M
Enterprise Value
81.11M
1-Year Change
-12.77%
Ranking
Category
Stock Price
$7.60
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $175.05M, an increase of 92.16%. That is a compound annual growth rate of 15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 173.21M | -1.82% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 336.76B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 277.50B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 233.02B |
| AstraZeneca | 216.19B |